|
Variables
|
EBER ISH status
|
p value
|
|---|
|
EBER positive (+)
|
EBER negative (−)
|
|---|
|
Sex
| | |
0.003*
|
|
male
|
82/2504 (3.3%)
|
1717/2504 (68.6%)
| |
|
female
|
14/2504 (0.6%)
|
691/2504 (27.5%)
| |
|
Lauren type
| | |
0.000*
|
|
Diffuse/mixed
|
77/2504 (3.1%)
|
1503/2504 (60%)
| |
|
intestinal
|
19/2504 (0.8%)
|
905/2504 (36.1%)
| |
|
Differentiation
| | |
0.001*
|
|
poorly differentiated
|
79/2504 (3.1%)
|
1600/2504 (63.9%)
| |
|
well-moderately
|
17/2504 (0.7%)
|
808/2504 (32.3%)
| |
|
T stage
| | |
0.322
|
|
pT3 + T4
|
55/2504 (2.2%)
|
1500/2504 (59.9%)
| |
|
pT1 + T2
|
41/2504 (1.6%)
|
908/2504 (36.3%)
| |
|
Lymphnode metastasis
| | |
0.326
|
|
LNM+
|
53/2504 (2.1%)
|
1450/2504 (57.9%)
| |
|
LNM-
|
43/2504 (1.7%)
|
958/2504 (38.3%)
| |
|
PD-L1 expression
| | |
0.524
|
|
PD-L1 -
|
52/2358 (2.2%)
|
1617/2358 (68.6%)
| |
|
PD-L1 > =1%
|
25/2358 (1.1%)
|
664/2358 (28.1%)
| |
